Fenfluramine treatment in pediatric patients with Dravet syndrome reduces seizure burden and overall healthcare costs: A retrospective and observational real‐world study

Documenti analoghi

• Add‐on treatment with vinpocetine reduces seizure frequency and improves comorbidities in patients with loss‐of‐function γ‐aminobutyric acid type A receptor variants
  di: Cathrine E. Gjerulfsen, et al.
  Pubblicazione: (2026)
• Lack of effectiveness and seizure worsening with cenobamate in pediatric patients with Dravet syndrome
  di: Rita Cagigal, et al.
  Pubblicazione: (2025)
• Cenobamate as add‐on treatment for SCN8A developmental and epileptic encephalopathy
  di: Cathrine E. Gjerulfsen, et al.
  Pubblicazione: (2025)
• Pharmacological management of prolonged seizures in Dravet syndrome including intravenous phenytoin
  di: Rana Abi Tayeh, et al.
  Pubblicazione: (2024)
• Unmasking the role of the occipital lobe in epilepsy with eyelid myoclonia
  di: Emilia Ricci, et al.
  Pubblicazione: (2025)